Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on Melanized and Non-melanized Cryptococcus neoformans

Fátima Lisboa Fernandes, Orionalda; Costa, Carolina; Souza Lino Junior, Ruy; Vinaud, Marina; Hasimoto e Souza, Lúcia; Paula, Joelma; Rosário Rodrigues Silva, Maria
December 2012
Mycopathologia;Dec2012, Vol. 174 Issue 5/6, p421
Academic Journal
In the present study, the in vitro susceptibility and capsular width from both melanized and non-melanized Cryptococcus neoformans cells in the presence of Pimenta pseudocaryophyllus crude extract were determined. The results were compared with those obtained for voriconazole and amphotericin B. Melanization was obtained in minimal medium broth with the addition of L-dopa, and the antifungal susceptibility tests were performed using the broth microdilution method. Capsular width of 30 cells of each one of the isolates in medium with crude extracts of P. pseudocaryophyllus or voriconazole or amphotericin B at a concentration corresponding to 0.5 times the minimal inhibitory concentration (MIC) was measured, and the mean was calculated. The MICs and minimal fungicidal concentrations (MFCs) for plant extract and voriconazole were identical for both melanized and non-melanized C. neoformans isolates, but for amphotericin, the MFCs for melanized cells were up to 8 times higher than for non-melanized cells. The capsular width of C. neoformans cells was smaller ( p < 0.001) in the presence crude extract of P. pseudocaryophyllus and of voriconazole regardless melanization. The findings of capsule alterations of C. neoformans verified in this study provide fertile ways for future research into the effects of antifungal agents on the pathogenesis of cryptococcosis.


Related Articles

  • Resistance of Asian Cryptococcus neoformans Serotype A Is Confined to Few Microsatellite Genotypes. Weihua Pan; Kantarawee Khayhan; Ferry Hagen; Retno Wahyuningsih; Chakrabarti, Arunaloke; Chowdhary, Anuradha; Ikeda, Reiko; Taj-Aldeen, Saad J.; Khan, Ziauddin; Imran, Darma; Sjam, Ridhawati; Sriburee, Pojana; Wanqing Liao; Chaicumpar, Kunyaluk; Ingviya, Natnicha; Mouton, Johan W.; Curfs-Breuker, Ilse; Boekhout, Teun; Meis, Jacques F.; Klaassen, Corné H. W. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Cryptococcus neoformans is a pathogenic yeast that causes cryptococcosis, a life threatening disease. The prevalence of cryptococcosis in Asia has been rising after the onset of the AIDS epidemic and estimates indicate more than 120 cases per 1,000 HIV-infected individuals per year....

  • Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil. Favalessa, Olivia Cometti; Jesus de Paula, Daphine Ariadne; Dutra, Valéria; Nakazato, Luciano; Tadano, Tomoko; dos Santos Lazera, Márcia; Wanke, Bodo; Trilles, Luciana; Walderez Szeszs, Maria; Silva, Dayane; Hahn, Rosane Christine // Journal of Infection in Developing Countries;Aug2014, Vol. 8 Issue 8, p1037 

    Introduction: Cryptococcosis is a systemic fungal infection that affects humans and animals, mainly due to Cryptococcus neoformans and Cryptococcus gattii. Following the epidemic of acquired immunodeficiency syndrome (AIDS), fungal infections by C. neoformans have become more common among...

  • Amphotericin B in Cryptococcal Meningitis. Sarosi, George A.; Parker, James D.; Doto, Irene L.; Tosh, Fred E. // Annals of Internal Medicine;Dec69, Vol. 71 Issue 6, p1079 

    Describes treatment of patients with cryptococcal meningitis using intravenous amphotericin B. Clinical features of patients with cryptococcal meningitis; Results of therapy; Factors influencing survival.

  • Voriconazole, Combined with Amphotericin B, in the Treatment for Pulmonary Cryptococcosis Caused by C. neoformans (Serotype A) in Mice with Severe Combined Immunodeficiency (SCID). Silva, Eriques; Paula, Claudete; Assis Baroni, Francisco; Gambale, Walderez // Mycopathologia;Jun2012, Vol. 173 Issue 5/6, p445 

    Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast of the genus Cryptococcus neoformans. The model of systemic cryptococcosis in mice with severe combined immunodeficiency (SCID) is useful for immunological and therapeutic study of the disease in...

  • Management of cryptococcal meningitis in adults at Mthatha Hospital Complex, Eastern Cape, South Africa. Sogbanmu, O. O.; John, M. A.; Lalloo, U. // Southern African Journal of HIV Medicine;2014, Vol. 15 Issue 3, p104 

    Background. Cryptoccocal meningitis (CM) remains prevalent in HIV-infected individuals across South Africa (SA). Early diagnosis and management, aided by the existing Southern African HIV Clinicians Society (SAHIVSoc) 2007 guidelines on management of CM, could reduce the mortality associated...

  • First Isolation of Azole-Resistant Cryptococcus neoformans from Feline Cryptococcosis. Kano, Rui; Okubo, Miki; Yanai, Tokuma; Hasegawa, Atsuhiko; Kamata, Hiroshi // Mycopathologia;Dec2015, Vol. 180 Issue 5/6, p427 

    We report here, to the best of our knowledge, the first description of an in vitro fluconazole (FLZ)-resistant Cryptococcus neoformans var. grubii from a case of feline cryptococcosis. In vitro testing demonstrated that this isolate was resistant to FLZ (minimum inhibitory concentration, MIC, of...

  • Radioimmunotherapy Is More Effective than Antifungal Treatment in Experimental Cryptococcal Infection. Bryan, Ruth A.; Zewel Jiang; Howell, Robertha C.; Morgenstern, Alfred; Bruchertseifer, Frank; Casadevall, Arturo; Dadachova, Ekaterina // Journal of Infectious Diseases;8/15/2010, Vol. 202 Issue 4, p633 

    Radioimmunotherapy (RIT) prolongs the survival of mice infected with Cryptococcus neoformans. To compare the efficacy of RIT with that of amphotericin B, we infected AJ/ Cr mice intravenously with either nonmelanized or melanized C. neoformans cells. Infected mice were either left un-treated or...

  • In vitro antifungal activity of Satureja Khuzestanica Jamzad against Cryptococcus neoformans. Zarrin, Majid; Amirrajab, Nasrin; Sadeghi-Nejad, Batool // Pakistan Journal of Medical Sciences;Oct2010, Vol. 26 Issue 4, p880 

    Objective: Finding the antifungal activity of Satureja Khuzestanica Jamzad extract against Cryptococcus neoformans isolates. Methodology: The dilution in agar method was used to test the plant extracts against C. neoformans. The minimum inhibitory concentration (MIC) was described as the lowest...

  • Antifungal Activity of Extracts and Prenylated Coumarins Isolated from Baccharis darwinii Hook & Arn. (Asteraceae). Kurdelas, Rita R.; Lima, Beatriz; Tapia, Alejandro; Feresin, Gabriela Egly; Sierra, Manuel Gonzalez; Rodríguez, María Victoria; Zacchino, Susana; Enriz, Ricardo D.; Freile, Monica L. // Molecules;Jul2010, Vol. 15 Issue 7, p4898 

    The petroleum ether extract of Baccharis darwinii showed activity against Cryptococcus neoformans and dermatophytes. Bioactivity-guided fractionation of Baccharis darwinii has resulted in the isolation of three coumarins: 5′-hydroxy aurapten (anisocoumarin H, 1), aurapten...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics